JAZZ PHARMACEUTICALS PLC revenue for the last year amounted to 3.47 B EUR, the most of which — 3.47 B EUR — came from its highest performing source at the moment, Pharmaceutical Products, the year earlier bringing 3.42 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought JAZZ PHARMACEUTICALS PLC 3.16 B EUR, and the year before that — 3.15 B EUR.